Balance in Patients With Ectopic Bone Tissue After Total Hip Replacement
Posture Stability and Risk Fall Test in Objective Assessment of Balance in Patients With Ectopic Bone Tissue After Total Hip Replacement
1 other identifier
observational
88
1 country
1
Brief Summary
One of the typical complications which occurs after total hip replacement (THR) procedure is heterotopic ossification (HO). According to current studies abnormal formation of bone after trauma or replacement of the hip could reach even 90% of cases. Heterotopic ossifications are causing the following symptoms, such as: pain, swelling, erythema and warmth along with joint immobility. Those factors could have an impact on maintaining the posture, especially in patients after THR. It is well known since the 90s that the risk of fall among the population older than 65 is high. Data shows that over 30% of those people have such an incident at least once in a year. Majority of them do not have further consequences, however about 10% result in serious trauma to the head and musculoskeletal system. Falls of people who underwent THR are sometimes connected with periprosthetic fractures, which treatment is much more complicated and is associated with a higher risk of failure than treatment of ordinary fractures of the lower limb. What may even worsen the situation is that elderly people very often suffer from many diseases including osteoporosis or neoplasm which increase the risk of fracture. The rate of falls is even higher among patients hospitalised from hip fractures. In the first month after returning home about 14% of patients fall. During the 6 month period after hospitalisation it reaches 53%. So far, the influence of heterotopic ossifications on the risk of falls is unknown in the literature.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
January 19, 2022
CompletedFirst Posted
Study publicly available on registry
February 1, 2022
CompletedFebruary 1, 2022
January 1, 2022
6 months
January 19, 2022
January 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postural stability test
Results obtained from the participants were recorded as stability index (SI) values which represent deviations of platform position from the vertical in degrees. The higher SI values are, the more difficult it was for participants to maintain stability during the test.
6 months postoperatively
Risk of fall test
a single test consisted of the results obtained from three measurements. Each measurement was performed at level 6 of the platform stability for 20 seconds with a 10-second rest time between attempts. The person conducting the test informed the patient in advance of how the test would proceed and then gave verbal instructions during each test. The patients were positioned in the centre of the platform, both feet set with their feet shoulder-width apart. The final result of each test was a computerised risk of fall assessment report with patient scores related to normative data.
6 months postoperatively
Study Arms (2)
patients with heterotopic ossification
patients with heterotopic ossification following THR
patients without heterotopic ossification
patients without heterotopic ossification following THR
Interventions
Biomechanical analysis of risk fall in terms of balance
Eligibility Criteria
Patients undergoing total hip replacement, who developed heterotopic ossification during 6 months postoperatively.
You may qualify if:
- age between 60 and 80 years
- consent to particiapte in the study
- unilateral hip osteoarthritis
- primary hip osteoarthritis
You may not qualify if:
- neurological disorders
- diabetes mellitus
- any other surgery or lower limb injury during follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Othopedics and Rehabilitation, Medical University of Warsaw
Warsaw, 03-984, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Artur Stolarczyk, PhD, MD
Department of Orthopedics and Rehabilitation, Medical University of Warsaw
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of the Department of Orthopedics and Rehabilitation
Study Record Dates
First Submitted
January 19, 2022
First Posted
February 1, 2022
Study Start
January 1, 2020
Primary Completion
July 1, 2020
Study Completion
June 1, 2021
Last Updated
February 1, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
IPD will be shared after rationale request from the researcher.